Total Payments
$808,551
2024 Payments
$65,924
Companies
36
Transactions
2,131
Medicare Patients
809
Medicare Billing
$79,750
Payment Breakdown by Category
Other$664,471 (82.2%)
Travel$70,786 (8.8%)
Consulting$41,740 (5.2%)
Food & Beverage$31,525 (3.9%)
Education$29.43 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $653,587 | 349 | 80.8% |
| Travel and Lodging | $70,786 | 421 | 8.8% |
| Consulting Fee | $41,740 | 21 | 5.2% |
| Food and Beverage | $31,525 | 1,328 | 3.9% |
| Honoraria | $10,884 | 7 | 1.3% |
| Education | $29.43 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $231,677 | 432 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $180,101 | 287 | $0 (2022) |
| ITI, Inc. | $126,742 | 177 | $0 (2023) |
| ABBVIE INC. | $66,225 | 138 | $0 (2024) |
| Axsome Therapeutics, Inc. | $50,943 | 58 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $49,184 | 89 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $45,843 | 159 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33,944 | 48 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $11,122 | 25 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $2,678 | 57 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65,924 | 131 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($33,944) |
| 2023 | $134,750 | 249 | ITI, Inc. ($66,347) |
| 2022 | $91,562 | 251 | ITI, Inc. ($48,460) |
| 2021 | $65,368 | 233 | AbbVie Inc. ($35,152) |
| 2020 | $84,925 | 254 | Allergan, Inc. ($72,878) |
| 2019 | $117,272 | 319 | Allergan Inc. ($64,193) |
| 2018 | $152,200 | 419 | Sunovion Pharmaceuticals Inc. ($82,707) |
| 2017 | $96,550 | 275 | Sunovion Pharmaceuticals Inc. ($68,800) |
All Payment Transactions
2,131 individual payment records from CMS Open Payments — Page 1 of 86
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $13.11 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $115.71 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $13.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,680.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $41.54 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.30 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Neuropsychiatry | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Neuropsychiatry | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $195.64 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: CNS | ||||||
| 10/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Central Nervous System | ||||||
| 09/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $154.10 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 169 | 578 | $40,180 | $17,462 |
| 2022 | 1 | 169 | 733 | $51,310 | $17,874 |
| 2021 | 2 | 275 | 698 | $53,260 | $20,154 |
| 2020 | 1 | 196 | 757 | $71,915 | $24,260 |
Total Patients
809
Total Services
2,766
Medicare Billing
$79,750
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 155 | 564 | $39,480 | $17,302 | 43.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 14 | 14 | $700.00 | $160.55 | 22.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 169 | 733 | $51,310 | $17,874 | 34.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 164 | 522 | $36,540 | $14,893 | 40.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 176 | $16,720 | $5,261 | 31.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 196 | 757 | $71,915 | $24,260 | 33.7% |
About Dr. David Snow, MD
Dr. David Snow, MD is a Psychiatry healthcare provider based in Maryville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821096041.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Snow, MD has received a total of $808,551 in payments from pharmaceutical and medical device companies, with $65,924 received in 2024. These payments were reported across 2,131 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($653,587).
As a Medicare-enrolled provider, Snow has provided services to 809 Medicare beneficiaries, totaling 2,766 services with total Medicare billing of $79,750. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Maryville, TN
- Active Since 07/12/2005
- Last Updated 11/22/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1821096041
Products in Payments
- VRAYLAR (Drug) $297,901
- LATUDA (Drug) $180,101
- CAPLYTA (Drug) $160,686
- Auvelity (Drug) $50,943
- REXULTI (Drug) $46,568
- QELBREE (Drug) $39,645
- Qelbree (Drug) $9,516
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $8,094
- JORNAY PM (Drug) $3,029
- FANAPT (Drug) $1,971
- INGREZZA (Drug) $1,364
- AUSTEDO (Drug) $922.00
- HETLIOZ (Drug) $609.72
- TRINTELLIX (Drug) $519.56
- Horizant (Drug) $515.75
- ABILIFY MAINTENA (Drug) $494.36
- Adzenys XR-ODT (Drug) $453.95
- NUEDEXTA (Drug) $440.85
- APLENZIN (Drug) $399.73
- Evekeo (Drug) $380.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Maryville
Dr. Sanjay Nigam, Md, MD
Psychiatry — Payments: $88,131
Psychiatry $88,131
Dr. Alejandro Amante, M.d, M.D
Psychiatry — Payments: $30,428
Psychiatry $30,428
Sharon Chastain, Md, MD
Psychiatry — Payments: $10,833
Psychiatry $10,833
Veronica Gubatan, Md, MD
Psychiatry — Payments: $4,189
Psychiatry $4,189
Dr. Kelly Ownby, M.d, M.D
Psychiatry — Payments: $3,920
Psychiatry $3,920
William Wilson, Md, MD
Psychiatry — Payments: $2,228
Psychiatry $2,228